Litcius/Paper detail

Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial

Arash Gholoobi, Vahid Reza Askari, Hossein Naghedinia, Mostafa Ahmadi, Vida Vakili, Vafa Baradaran Rahimi

2021Inflammopharmacology53 citationsDOI

Topics & Concepts

ColchicineMedicinePlaceboInternal medicineMyocardial infarctionC-reactive proteinGoutGastroenterologyBiomarkerPericarditisInflammationSurgeryCardiologyPathologyBiochemistryAlternative medicineChemistryInflammasome and immune disordersAdipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity
Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial | Litcius